Clearside Biomedical, Inc. (CLSD)

NASDAQ: CLSD · IEX Real-Time Price · USD

1.410

+0.100 (7.63%)

At close: Apr 22, 2024, 4:00 PM

1.390

-0.020 (-1.42%)

After-hours: Apr 22, 2024, 7:59 PM EDT

Clearside Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	28.92	48.26	30.44	17.55	22.96	8.4	9.58	35.18	20.28	8.27
Short-Term Investments	0	0	0	0	0	32.84	28.42	48.81	0	0
Cash & Cash Equivalents	28.92	48.26	30.44	17.55	22.96	41.24	38	83.99	20.28	8.27
Cash Growth	-40.07%	58.56%	73.45%	-23.56%	-44.34%	8.52%	-54.76%	314.10%	145.29%	-
Receivables	0.17	0	10	0	0	0	0	0	0	0
Other Current Assets	1.03	1.14	1.7	0.57	2.26	1.71	1.2	0.33	0.2	0.05
Total Current Assets	30.12	49.4	42.14	18.12	25.22	42.94	39.2	84.32	20.48	8.32
Property, Plant & Equipment	3.87	1.87	0.61	0.94	1.2	0.79	0.89	0.09	0.16	0.21
Other Long-Term Assets	0.03	0.03	0.16	0.26	0.36	0.39	0.41	0.4	0.42	1.77
Total Long-Term Assets	3.9	1.9	0.77	1.2	1.56	1.18	1.29	0.5	0.57	1.98
Total Assets	34.02	51.3	42.9	19.32	26.78	44.12	40.49	84.81	21.06	10.3
Accounts Payable	2.21	1.05	0.94	2	1.28	6.87	5.38	2.59	1.47	1.26
Deferred Revenue	0.08	0.21	0	5	5	0	0.14	0.16	0.7	0.2
Current Debt	0.36	0.35	0.39	1.36	1.69	0.56	3.2	0	1.73	0
Other Current Liabilities	4.17	4.18	3.31	1.58	2.93	3.05	4.8	2.65	1.29	0.97
Total Current Liabilities	6.81	5.78	4.64	9.94	10.9	10.48	13.52	5.41	5.2	2.42
Long-Term Debt	42.64	34.91	0.29	0.62	4.72	9.42	4.81	7.59	4.24	0
Other Long-Term Liabilities	0.48	0	0	0	0	0.61	0.75	0.16	0.96	0.25
Total Long-Term Liabilities	43.12	34.91	0.29	0.62	4.72	10.02	5.56	7.75	5.2	0.25
Total Liabilities	49.93	40.7	4.93	10.56	15.62	20.5	19.08	13.15	10.4	2.68
Total Debt	43	35.26	0.68	1.98	6.41	9.98	8.01	7.59	5.98	0
Debt Growth	21.95%	5124.00%	-65.91%	-69.11%	-35.75%	24.55%	5.58%	26.94%	-	-
Retained Earnings	-320.92	-288.44	-255.49	-255.87	-237.66	-206.89	-124.22	-65.25	-39.36	-21.72
Comprehensive Income	0	0	0	0	0	0	-0.01	-0.01	0	0
Shareholders' Equity	-15.91	10.61	37.98	8.76	11.16	23.62	21.42	71.66	-36.66	-19.21
Net Cash / Debt	-14.08	13	29.76	15.57	16.55	31.26	29.99	76.41	14.31	8.27
Net Cash / Debt Growth	-	-56.33%	91.18%	-5.92%	-47.07%	4.24%	-60.75%	434.04%	73.02%	-
Net Cash Per Share	-0.23	0.22	0.50	0.33	0.43	1.02	1.18	5.83	6.12	4.76
Working Capital	23.31	43.62	37.5	8.18	14.32	32.47	25.68	78.91	15.29	5.9
Book Value Per Share	-0.26	0.18	0.65	0.19	0.29	0.77	0.85	5.47	-15.67	-11.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).